Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy

NCT01050504 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01050504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01050504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy
Lead sponsor
University of Washington
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2009
Completion date
January 31, 2029
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized renal pelvis and ureter urothelial carcinoma, malignant solid neoplasm, metastatic malignant neoplasm in the bone, metastatic malignant neoplasm in the soft tissues, metastatic renal pelvis and ureter urothelial carcinoma, recurrent bladder carcinoma, recurrent prostate carcinoma, recurrent renal pelvis and ureter urothelial carcinoma, stage iv bladder cancer ajcc v7, stage iv bladder urothelial carcinoma ajcc v7, stage iv prostate cancer ajcc v7